Pharmaceuticals
Comparative Effects of IL-17 and IL-23 Inhibitors on Lipid Profiles and Lipid-Derived Atherogenic Indices in Patients with Psoriasis
Par Celik C, Çelik MS et Cepik N.
Contenu en anglais
Résumé
Background
Psoriasis is associated with increased cardiovascular risk and altered lipid metabolism. The comparative effects of IL-17 and IL-23 inhibitors on lipid-derived atherogenic indices remain unclear.
Objective
To compare the effects of IL-17 and IL-23 inhibitors on lipid parameters and lipid-derived atherogenic indices in patients with psoriasis.